Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
All articles by Jamie Bell
Jamie Bell
-
-
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
-
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
-
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
-
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
-
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
-
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
-
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
-
‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks
Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…
-
‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks
Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…